Exenatide vs Insulin Glargine for Body Fat and Cardiac Biomarker Effects

exenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagonexenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagon

exenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagonexenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagon

exenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagonexenatide, diabetes mellitus, insulin glargine, high-sensitive C-reactive protein, hs-CRP, glycemic control, metformin, visceral fat mass, adiponectin, leptin, glucagon